Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing.Its product candidates targets the treatment of HIV/AIDS, hemophilia A and B, hurler syndrome (MPS I), fabry disease, Huntington’s disease and many others.
Its ZFPs based products are used in various applications such as human therapeutics, research reagents, pharmaceutical protein production, plant agriculture, cell-line engineering and production of transgenic animals.The company has presence in the UK and the US.
Sangamo is headquartered in Richmond, California, the US.
Sangamo Therapeutics Inc (SGMO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 Summary According to the recently published report ’Tyrosine Protein Kinase JAK1 - Drugs in Development, 2021’; Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target constitutes...
240 pages •
By Asia Market Information & Development Company
• Apr 2021
China’s demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
190 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Laboratory Plate Handling Systems Market to Reach $476.6 Million by 2027
- Amid the COVID-19 crisis, the global market for Laboratory Plate Handling Systems estimated at US$341.9 Million in the year 2020, is projected to reach a revised size of US$476.6 Million by 2027, growing at a CAGR of 4.9%...
178 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Aesthetic Thread Market to Reach $704.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Aesthetic Thread estimated at US$525.3 Million in the year 2020, is projected to reach a revised size of US$704.8 Million by 2027, growing at aCAGR of 4.3% over the period 2020-2027. Suspension...
295 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Diacetone Alcohol Market to Reach $1.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Diacetone Alcohol estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. Solvents,...
129 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Gel Permeation Chromatography Systems Market to Reach $1.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Gel Permeation Chromatography Systems estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.6%...
187 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Viscosupplementation Market to Reach $6.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Viscosupplementation estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$6.8 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027....
193 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Bio Vanillin Market to Reach $249.1 Million by 2027
- Amid the COVID-19 crisis, the global market for Bio Vanillin estimated at US$169.5 Million in the year 2020, is projected to reach a revised size of US$249.1 Million by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Food...
200 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Carbon Disulfide Market to Reach $169.7 Million by 2027
- Amid the COVID-19 crisis, the global market for Carbon Disulfide estimated at US$142 Million in the year 2020, is projected to reach a revised size of US$169.7 Million by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027....
134 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Chemotherapy-induced Nausea and Vomiting Drugs Market to Reach $3.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Chemotherapy-induced Nausea and Vomiting Drugs estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing...
Pharmaceutical
Chemotherapy
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.